Mark Booth
Algemeen Directeur bij NetJets Europe Ltd.
Actieve functies van Mark Booth
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
NetJets Europe Ltd.
 NetJets Europe Ltd. AirlinesTransportation Part of Berkshire Hathaway, Inc., NetJets Europe Ltd. runs a fleet of aircrafts. The company is based in Rotkreuz, Switzerland. The CEO of the Swiss company is Mark Booth. | Algemeen Directeur | - | - |
| Voorzitter | - | - | |
The Michael J. Fox Foundation for Parkinson's Research
 The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | Directeur/Bestuurslid | 01-01-2011 | - |
Loopbaan van Mark Booth
Statistieken
Internationaal
| Zwitserland | 2 |
| Verenigde Staten | 2 |
Operationeel
| Chief Executive Officer | 1 |
| Chairman | 1 |
| Director/Board Member | 1 |
Sectoraal
| Transportation | 2 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
NetJets Europe Ltd.
NetJets Europe Ltd. AirlinesTransportation Part of Berkshire Hathaway, Inc., NetJets Europe Ltd. runs a fleet of aircrafts. The company is based in Rotkreuz, Switzerland. The CEO of the Swiss company is Mark Booth. | Transportation |
The Michael J. Fox Foundation for Parkinson's Research
The Michael J. Fox Foundation for Parkinson's Research Miscellaneous Commercial ServicesCommercial Services The Michael J. Fox Foundation for Parkinson's Research engages in finding a cure for Parkinson's disease within the decade through funded research agenda and to ensuring the development of improved therapies for those living with Parkinson's. It is delivering patients better treatments and, ultimately, a cure for Parkinson's disease. It developed a targeted approach to research funding that helps them identify and prioritize the patient-relevant science. The company was founded by Michael J. Fox and Deborah W. Brooks in 2000 and is headquartered in New York, NY. | Commercial Services |
- Beurs
- Insiders
- Mark Booth
- Ervaring
